XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2025
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS  
Schedule of stock were valued on the date of issuance using the Monte Carlo pricing model with the following assumptions

    

Series A Right Warrant

    

Series B Right Warrant

Common Stock Price as of Issuance Date

$

0.94

$

0.94

Risk-Free Rate

4.31

%

 

4.27

%

Dividend Rate

0.00

%

 

0.00

%

Volatility

88.90

%

 

97.19

%

Minimum Exercise Price

$

1.00

$

2.00

Maximum Exercise Price

$

2.00

$

4.00

Formula for Exercise Price

90% of the 5-day volume weighted average stock price as of the exercise date rounded down to the nearest cent, not to fall outside the range of the maximum and minimum exercise prices.

Schedule of stock-based compensation expense

    

Three Months Ended March 31,

Stock-based compensation expense by category

2025

    

2024

Stock-options

$

679,148

$

734,210

Restricted stock-units (“RSUs”)

 

139,278

 

225,255

Total stock-based compensation expense

$

818,426

$

959,465

Schedule of stock options activity

Weighted

Weighted

Average

Average

Remaining

Exercise Price

Contractual

    

Shares

    

per Share

    

Life (Years)

Outstanding, December 31, 2024

 

12,341,914

$

3.55

6.81

Granted

 

39,500

1.03

 

Forfeited

 

(46,876)

2.05

 

Expired

 

(34,781)

5.27

 

Outstanding, March 31, 2025

 

12,299,757

$

3.54

 

6.74

Schedule of fair value of each stock option estimated using the Black-Scholes pricing model

The Company estimated the fair value of stock options granted during the three months ended March 31, 2025 using a Black-Scholes pricing model, which used the following inputs:

Exercise price (per share)

$

1.01 - $1.30

Expected volatility

 

80.7

%

Expected term*

 

6 years

Risk free rate

 

4.01% - 4.40

%

Dividends

 

0

%

Schedule of intrinsic value

The intrinsic value is calculated as the difference between the market value of the shares as of March 31, 2025, of $1.00 and the exercise price of the shares.

Options Outstanding

Number

Weighted

Weighted

Range of

Outstanding at

Average

Average

Aggregate

Exercise

March 31, 

Exercise

Remaining

Intrinsic

Price

    

2025

    

Price

    

Life (Years)

    

Value

$0.84 - $13.20

 

12,299,757

$

3.54

6.74

$

138,015

Options Exercisable

Number

Weighted

  

Exercisable at

Average

Aggregate

March 31, 

Exercise

Intrinsic

2025

    

Price

    

Value

6,949,591

$

4.98

$

32,038

Schedule of company's non-vested options

Weighted

Average

Grant Date

    

Shares

    

Fair Value

Non-vested, December 31, 2024

 

6,234,550

$

1.09

Granted

 

39,500

$

0.75

Forfeited

 

(46,876)

$

1.34

Vested

 

(877,008)

$

1.02

Non-vested, March 31, 2025

 

5,350,166

$

1.10

Schedule of outstanding balance of restricted stock units

Total

Intrinsic Value

Outstanding, December 31, 2024

 

2,809,500

 

$

2,556,645

Granted

 

43,500

 

Vested

(35,000)

Forfeited

 

(30,500)

 

Outstanding, March 31, 2025

 

2,787,500

$

2,787,500

Schedule of the restricted stock unit activity

Weighted

Average

Grant Date

    

Shares

    

Fair Value

Non-vested, January 1, 2025

 

641,336

$

1.31

Granted

35,000

1.03

Vested

 

(65,000)

0.96

Non-vested, March 31, 2025

 

611,336

$

1.33